Francesca Iannantuoni

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 4

Top Topics

Staphylococcus Aureus

Amyotrophic Lateral Sclerosis

Mitochondrial Dna

Oxidative Stress

Top Venues

Journal of clinical medicine

Fisabio (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Fisabio

Spain

PHD :: Hospital Dr.Peset - Laboratorio traslacional de endocrinologia y nutricción

Publications

Francesca Iannantuoni, Aranzazu M de Marañon, Zaida Abad-Jiménez, Francisco Canet, Pedro Díaz-Pozo, Sandra López-Domènech, Carlos Morillas, Milagros Rocha, Víctor Manuel Víctor
Mitochondrial Alterations and Enhanced Human Leukocyte/Endothelial Cell Interactions in Type 1 Diabetes. Journal of clinical medicine 9 (7) (2020)
Irene Escribano-López, Aranzazu M de Marañon, Francesca Iannantuoni, Sandra López-Domènech, Zaida Abad-Jiménez, Pedro Díaz, Eva Solá, Nadezda Apostolova, Milagros Rocha, Víctor Manuel Víctor
The Mitochondrial Antioxidant SS-31 Modulates Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Type 2 Diabetes. Journal of clinical medicine 8 (9) (2019)
Francesca Iannantuoni, Aranzazu M de Marañon, Noelia Díaz-Morales, Rosa Falcon, Celia Bañuls, Zaida Abad-Jimenez, Víctor Manuel Víctor, Antonio Hernández-Mijares, Susana Rovira-Llopis
The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes. Journal of clinical medicine 8 (11) (2019)
Noelia Díaz-Morales, Sandra Lopez-Domenech, Francesca Iannantuoni, Ester Lopez-Gallardo, Eva Sola, Carlos Morillas, Milagros Rocha, Eduardo Ruiz-Pesini, Víctor Manuel Víctor
Mitochondrial DNA Haplogroup JT is Related to Impaired Glycaemic Control and Renal Function in Type 2 Diabetic Patients. Journal of clinical medicine 7 (8) (2018)